Laurel Wealth Advisors (North Carolina)’s Regeneron Pharmaceuticals REGN Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	-$4K	–	596
2022 Q2	$4K	Hold	6	–	–	﹤0.01%	475
2022 Q1	$4K	Hold	6	–	–	﹤0.01%	513
2021 Q4	$4K	Hold	6	–	–	﹤0.01%	515
2021 Q3	$4K	Hold	6	–	–	﹤0.01%	517
2021 Q2	$3K	Hold	6	–	–	﹤0.01%	632
2021 Q1	$3K	Sell	6 -15	-71%	-$7.3K	﹤0.01%	573
2020 Q4	$10K	Buy	21 +6	+40%	+$3.24K	﹤0.01%	417
2020 Q3	$8K	Hold	15	–	–	﹤0.01%	400
2020 Q2	$9K	Hold	15	–	–	﹤0.01%	387
2020 Q1	$7K	Buy	+15	New	+$6.19K	﹤0.01%	391

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s REGN Position: Q3 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 6 shares — an estimated $4K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in REGN in Q1 2020 and held it in 10 quarters. The position peaked at $10K in Q4 2020. 1,080 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

Laurel Wealth Advisors (North Carolina) reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Laurel Wealth Advisors (North Carolina) sold 6 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $4K.
Laurel Wealth Advisors (North Carolina) first reported a position in Regeneron Pharmaceuticals in Q1 2020 and held it in 10 quarters.
Laurel Wealth Advisors (North Carolina)'s Regeneron Pharmaceuticals position peaked at $10K in Q4 2020.
1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2022, filed 15 Nov 2022.